Logo image of GRA

W.R. Grace & Company (GRA) Stock Fundamental Analysis

NYSE:GRA - New York Stock Exchange, Inc. -

69.99  +0.02 (+0.03%)

After market: 69.99 0 (0%)

Fundamental Rating

2

Overall GRA gets a fundamental rating of 2 out of 10. We evaluated GRA against 85 industry peers in the Chemicals industry. Both the profitability and financial health of GRA have multiple concerns. GRA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GRA was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 1.76%
ROE 22.09%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 16.06%
PM (TTM) 4.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

GRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.48, we must say that GRA is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 6.48 is on the high side and indicates that GRA has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 6.48
Debt/FCF N/A
Altman-Z 1.48
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.71 indicates that GRA should not have too much problems paying its short term obligations.
A Quick Ratio of 1.11 indicates that GRA should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.11

More info and screens

4

3. Growth

3.1 Past

The earnings per share for GRA have decreased by -8.88% in the last year.
The earnings per share for GRA have been decreasing by -11.20% on average. This is quite bad
GRA shows a small growth in Revenue. In the last year, the Revenue has grown by 2.42%.
The Revenue has been growing slightly by 1.22% on average over the past years.
EPS 1Y (TTM)-8.88%
EPS 3Y-8.09%
EPS 5Y-11.2%
EPS Q2Q%106.12%
Revenue 1Y (TTM)2.42%
Revenue growth 3Y0.26%
Revenue growth 5Y1.22%
Sales Q2Q%22.5%

3.2 Future

Based on estimates for the next years, GRA will show a very strong growth in Earnings Per Share. The EPS will grow by 22.11% on average per year.
GRA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.63% yearly.
EPS Next Y46.76%
EPS Next 2Y33.41%
EPS Next 3Y26.09%
EPS Next 5Y22.11%
Revenue Next Year11.69%
Revenue Next 2Y9.11%
Revenue Next 3Y8.47%
Revenue Next 5Y7.63%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GRA Yearly Revenue VS EstimatesGRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
GRA Yearly EPS VS EstimatesGRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.01 indicates a rather expensive valuation of GRA.
GRA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.95, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.89 indicates a correct valuation of GRA.
When comparing the Price/Forward Earnings ratio of GRA to the average of the S&P500 Index (20.99), we can say GRA is valued slightly cheaper.
Industry RankSector Rank
PE 22.01
Fwd PE 14.89
GRA Price Earnings VS Forward Price EarningsGRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.12
GRA Per share dataGRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

GRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GRA's earnings are expected to grow with 26.09% in the coming years.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y33.41%
EPS Next 3Y26.09%

More info and screens

3

5. Dividend

5.1 Amount

GRA has a yearly dividend return of 0.90%, which is pretty low.
Compared to an average S&P500 Dividend Yield of 2.41, GRA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.9%

5.2 History

The dividend of GRA has a limited annual growth rate of 4.32%.
GRA has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)4.32%
Div Incr YearsN/A
Div Non Decr YearsN/A
GRA Yearly Dividends per shareGRA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

79.82% of the earnings are spent on dividend by GRA. This is not a sustainable payout ratio.
GRA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP79.82%
EPS Next 2Y33.41%
EPS Next 3Y26.09%
GRA Dividend Payout.GRA Dividend Payout, showing the Payout Ratio.GRA Dividend Payout.PayoutRetained Earnings

More info and screens

W.R. Grace & Company

NYSE:GRA (9/21/2021, 8:04:00 PM)

After market: 69.99 0 (0%)

69.99

+0.02 (+0.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.91%
Inst Owner Change0%
Ins Owners0.82%
Ins Owner Change0%
Market Cap4.64B
Analysts60
Price Target71.4 (2.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.9%
Yearly Dividend0.63
Dividend Growth(5Y)4.32%
DP79.82%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.01
Fwd PE 14.89
P/S 2.49
P/FCF N/A
P/OCF N/A
P/B 13.25
P/tB N/A
EV/EBITDA 16.12
EPS(TTM)3.18
EY4.54%
EPS(NY)4.7
Fwd EY6.71%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS28.06
BVpS5.28
TBVpSN/A
PEG (NY)0.47
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.76%
ROE 22.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 16.06%
PM (TTM) 4.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 6.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.11
Altman-Z 1.48
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.88%
EPS 3Y-8.09%
EPS 5Y-11.2%
EPS Q2Q%106.12%
EPS Next Y46.76%
EPS Next 2Y33.41%
EPS Next 3Y26.09%
EPS Next 5Y22.11%
Revenue 1Y (TTM)2.42%
Revenue growth 3Y0.26%
Revenue growth 5Y1.22%
Sales Q2Q%22.5%
Revenue Next Year11.69%
Revenue Next 2Y9.11%
Revenue Next 3Y8.47%
Revenue Next 5Y7.63%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A